The Role of Cytidine Deaminases on Innate Immune Responses against Human Viral Infections
暂无分享,去创建一个
[1] E. Petersen,et al. Herpes simplex viruses. , 2009 .
[2] E. Clercq. Frontiers in Microbiology , 1987, New Perspectives in Clinical Microbiology.
[3] S. Jonjić,et al. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.
[4] P Rudge,et al. In vivo cellular tropism of human T-cell leukemia virus type 1 , 1990, Journal of virology.
[5] Hui Zhu,et al. Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation. , 1991, The Journal of biological chemistry.
[6] C. Burant,et al. Molecular cloning of an apolipoprotein B messenger RNA editing protein. , 1993, Science.
[7] R. Espinosa,et al. Assignment of the gene encoding the human apolipoprotein B mRNA editing enzyme (APOBEC1) to chromosome 12p13.1. , 1994, Genomics.
[8] S. Wain-Hobson,et al. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy , 1995, Journal of virology.
[9] S. Wain-Hobson,et al. Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells. , 1996, Blood.
[10] A. Meyerhans,et al. HIV genetic variation is directed and restricted by DNA precursor availability. , 1997, Journal of molecular biology.
[11] Y. Yang,et al. Multiple protein domains determine the cell type-specific nuclear distribution of the catalytic subunit required for apolipoprotein B mRNA editing. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Günther,et al. Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G-->A hypermutation. , 1997, Virology.
[13] S. Wain-Hobson,et al. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy , 1998, Oncogene.
[14] L. Chan,et al. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family. , 1999, Biochemical and biophysical research communications.
[15] T. Honjo,et al. Specific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells* , 1999, The Journal of Biological Chemistry.
[16] R. Bartenschlager,et al. Replication of hepatitis C virus. , 2000, The Journal of general virology.
[17] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[18] M. Taniwaki,et al. Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. , 2000, Genomics.
[19] Nicholas O. Davidson,et al. An AU-Rich Sequence Element (UUUN[A/U]U) Downstream of the Edited C in Apolipoprotein B mRNA Is a High-Affinity Binding Site for Apobec-1: Binding of Apobec-1 to This Motif in the 3′ Untranslated Region of c-myc Increases mRNA Stability , 2000, Molecular and Cellular Biology.
[20] Bernard Roizman,et al. Herpes simplex virus infections , 2001, The Lancet.
[21] S. Anant,et al. Molecular mechanisms of apolipoprotein B mRNA editing , 2001, Current opinion in lipidology.
[22] Ding-Shinn Chen,et al. Global control of hepatitis B virus infection. , 2002, The Lancet. Infectious diseases.
[23] I. Dunham,et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. , 2002, Genomics.
[24] N. Ballatori,et al. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors. , 2002, Journal of cell science.
[25] C. Milstein,et al. AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[26] Reuben S Harris,et al. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. , 2002, Molecular cell.
[27] M. Malim,et al. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif , 2003, Nature Medicine.
[28] M. Malim,et al. DNA Deamination Mediates Innate Immunity to Retroviral Infection , 2003, Cell.
[29] Reuben S Harris,et al. The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G , 2003, Current Biology.
[30] F. Clavel,et al. Hypermutation of HIV-1 DNA in the Absence of the Vif Protein , 2003, Science.
[31] R. König,et al. Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif , 2003, Cell.
[32] M. Khan,et al. The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity. , 2003 .
[33] Yunkai Yu,et al. Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex , 2003, Science.
[34] W. Greene,et al. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. , 2003, Molecular cell.
[35] F. Papavasiliou,et al. AID Mediates Hypermutation by Deaminating Single Stranded DNA , 2003, The Journal of experimental medicine.
[36] M. Goodman,et al. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Wedekind,et al. Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. , 2003, Trends in genetics : TIG.
[38] B. Cullen,et al. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins , 2004, The EMBO journal.
[39] B. Cullen,et al. Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. , 2004, Virology.
[40] D. Pérez-Caballero,et al. APOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles , 2004, Journal of Virology.
[41] Reuben S Harris,et al. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. , 2004, Journal of molecular biology.
[42] D. Trono,et al. Response to Comment on "Inhibition of Hepatitis B Virus Replication by APOBEC3G" , 2004, Science.
[43] Reiko Shinkura,et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1 , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Malim,et al. Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins , 2004, Current Biology.
[45] Amalio Telenti,et al. APOBEC3G Genetic Variants and Their Influence on the Progression to AIDS , 2004, Journal of Virology.
[46] B. Strack,et al. Vif Overcomes the Innate Antiviral Activity of APOBEC3G by Promoting Its Degradation in the Ubiquitin-Proteasome Pathway* , 2004, Journal of Biological Chemistry.
[47] Xianghui Yu,et al. Amino-Terminal Region of the Human Immunodeficiency Virus Type 1 Nucleocapsid Is Required for Human APOBEC3G Packaging , 2004, Journal of Virology.
[48] E. Decroly,et al. HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles. , 2004, Biochemical and biophysical research communications.
[49] L. Kleiman,et al. The Interaction between HIV-1 Gag and APOBEC3G* , 2004, Journal of Biological Chemistry.
[50] M. Watson,et al. Activation-induced Cytosine Deaminase (AID) Is Actively Exported out of the Nucleus but Retained by the Induction of DNA Breaks* , 2004, Journal of Biological Chemistry.
[51] M. Malim,et al. APOBEC-Mediated Editing of Viral RNA , 2004, Science.
[52] T. Alce,et al. APOBEC3G Is Incorporated into Virus-like Particles by a Direct Interaction with HIV-1 Gag Nucleocapsid Protein* , 2004, Journal of Biological Chemistry.
[53] W. Brown,et al. APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo , 2004, Current Biology.
[54] V. Pathak,et al. Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAs* , 2004, Journal of Biological Chemistry.
[55] Reuben S. Harris,et al. Retroviral restriction by APOBEC proteins , 2004, Nature Reviews Immunology.
[56] R. König,et al. APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication* , 2004, Journal of Biological Chemistry.
[57] Vasco M. Barreto,et al. Somatic Hypermutation Is Limited by CRM1-dependent Nuclear Export of Activation-induced Deaminase , 2004, The Journal of experimental medicine.
[58] M. Malim,et al. Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity , 2005, Current Biology.
[59] R. König,et al. Complementary function of the two catalytic domains of APOBEC3G. , 2005, Virology.
[60] D. Nissley,et al. APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[61] Samantha G. Zeitlin,et al. Human Immunodeficiency Virus Type 1 Vpr Induces the Degradation of the UNG and SMUG Uracil-DNA Glycosylases , 2005, Journal of Virology.
[62] S. Heath,et al. Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort. , 2005, The Journal of infectious diseases.
[63] S. Wain-Hobson,et al. Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases. , 2005, The Journal of general virology.
[64] S. Wain-Hobson,et al. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[65] E. Koonin,et al. APOBEC4, a New Member of the AID/APOBEC Family of Polynucleotide (Deoxy)Cytidine Deaminases Predicted by Computational Analysis , 2005, Cell cycle.
[66] R. Reichman. Herpes simplex virus infections , 1984, European Journal of Clinical Microbiology.
[67] R. Reichman,et al. APOBEC3G/CEM15 (hA3G) mRNA Levels Associate Inversely with Human Immunodeficiency Virus Viremia , 2005, Journal of Virology.
[68] B. Cullen,et al. Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. , 2005, Virology.
[69] Amane Sasada,et al. APOBEC3G targets human T-cell leukemia virus type 1 , 2005, Retrovirology.
[70] M. Neuberger,et al. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. , 2005, Molecular biology and evolution.
[71] T. Heidmann,et al. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses , 2005, Nature.
[72] M. Malim,et al. APOBEC‐mediated interference with hepadnavirus production , 2005, Hepatology.
[73] W. Greene,et al. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells , 2005, Nature.
[74] M. Marin,et al. The Anti-HIV-1 Editing Enzyme APOBEC3G Binds HIV-1 RNA and Messenger RNAs That Shuttle between Polysomes and Stress Granules* , 2006, Journal of Biological Chemistry.
[75] N. Davidson,et al. APOBEC3F and APOBEC3G mRNA Levels Do Not Correlate with Human Immunodeficiency Virus Type 1 Plasma Viremia or CD4+ T-Cell Count , 2006, Journal of Virology.
[76] M. Alary,et al. APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians , 2006, AIDS.
[77] B. Cullen,et al. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells , 2006, Nucleic acids research.
[78] W. J. Esselman,et al. Identification of APOBEC3DE as Another Antiretroviral Factor from the Human APOBEC Family , 2006, Journal of Virology.
[79] C. Moore,et al. Population Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic Variation , 2006, Journal of Virology.
[80] Amane Sasada,et al. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex. , 2006, Virology.
[81] M. Malim,et al. Antiviral Protein APOBEC3G Localizes to Ribonucleoprotein Complexes Found in P Bodies and Stress Granules , 2006, Journal of Virology.
[82] H. Seno,et al. Anti-viral protein APOBEC3G is induced by interferon-α stimulation in human hepatocytes , 2006 .
[83] S. Wain-Hobson,et al. Interferon‐inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication , 2006, Hepatology.
[84] M. Emerman,et al. Uracil DNA Glycosylase Is Dispensable for Human Immunodeficiency Virus Type 1 Replication and Does Not Contribute to the Antiviral Effects of the Cytidine Deaminase Apobec3G , 2006, Journal of Virology.
[85] K. Shimotohno,et al. High expression of APOBEC3G in patients infected with hepatitis C virus , 2006, Journal of Molecular Histology.
[86] W. Greene,et al. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation , 2006, The Journal of experimental medicine.
[87] J. Wedekind,et al. Nanostructures of APOBEC3G Support a Hierarchical Assembly Model of High Molecular Mass Ribonucleoprotein Particles from Dimeric Subunits* , 2006, Journal of Biological Chemistry.
[88] T. Heidmann,et al. Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses , 2006, Nucleic acids research.
[89] S. Calattini,et al. Restriction of Foamy Viruses by APOBEC Cytidine Deaminases , 2006, Journal of Virology.
[90] J. V. Moran,et al. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[91] W. Greene,et al. High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition , 2006, Proceedings of the National Academy of Sciences.
[92] M. Levrero. Viral hepatitis and liver cancer: the case of hepatitis C , 2006, Oncogene.
[93] N. Muñoz,et al. HPV in the etiology of human cancer , 2006 .
[94] R. Medzhitov,et al. Type I interferons in host defense. , 2006, Immunity.
[95] T. Rana,et al. Human Retroviral Host Restriction Factors APOBEC3G and APOBEC3F Localize to mRNA Processing Bodies , 2006, PLoS pathogens.
[96] L. Kleiman,et al. Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication. , 2006, Journal of virology.
[97] C. Tian,et al. Differential Inhibition of Long Interspersed Element 1 by APOBEC3 Does Not Correlate with High-Molecular-Mass-Complex Formation or P-Body Association , 2006, Journal of Virology.
[98] M. Malim,et al. Antiviral Potency of APOBEC Proteins Does Not Correlate with Cytidine Deamination , 2006, Journal of Virology.
[99] D. Trono,et al. Induction of Antiviral Cytidine Deaminases Does Not Explain the Inhibition of Hepatitis B Virus Replication by Interferons , 2007, Journal of Virology.
[100] Jianming Hu,et al. Deamination-Independent Inhibition of Hepatitis B Virus Reverse Transcription by APOBEC3G , 2007, Journal of Virology.
[101] W. Greene,et al. Distinct Patterns of Cytokine Regulation of APOBEC3G Expression and Activity in Primary Lymphocytes, Macrophages, and Dendritic Cells* , 2006, Journal of Biological Chemistry.
[102] M. Imamura,et al. Dual effect of APOBEC3G on Hepatitis B virus. , 2007, The Journal of general virology.
[103] W. Greene,et al. Newly Synthesized APOBEC3G Is Incorporated into HIV Virions, Inhibited by HIV RNA, and Subsequently Activated by RNase H , 2007, PLoS pathogens.
[104] G. Heidecker,et al. Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid , 2007, Proceedings of the National Academy of Sciences.
[105] L. Kleiman,et al. APOBEC3G Inhibits DNA Strand Transfer during HIV-1 Reverse Transcription* , 2007, Journal of Biological Chemistry.
[106] W. Greene,et al. The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo1 , 2007, The Journal of Immunology.
[107] Shu Zheng,et al. Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma , 2007, Hepatology.
[108] M. Neuberger,et al. Molecular mechanisms of antibody somatic hypermutation. , 2007, Annual review of biochemistry.
[109] M. Khan,et al. Human Immunodeficiency Virus Type 1 Vif Inhibits Packaging and Antiviral Activity of a Degradation-Resistant APOBEC3G Variant , 2007, Journal of Virology.
[110] Patrick T. Dolan,et al. Biochemical Differentiation of APOBEC3F and APOBEC3G Proteins Associated with HIV-1 Life Cycle* , 2007, Journal of Biological Chemistry.
[111] M. Malim,et al. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C , 2007, Hepatology.
[112] A. Engelman,et al. Human Immunodeficiency Virus Type 1 cDNAs Produced in the Presence of APOBEC3G Exhibit Defects in Plus-Strand DNA Transfer and Integration , 2007, Journal of Virology.
[113] L. Lopalco,et al. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals. , 2007, The Journal of infectious diseases.
[114] J. V. Moran,et al. Selective inhibition of Alu retrotransposition by APOBEC3G. , 2007, Gene.
[115] E. Eichler,et al. Population Stratification of a Common APOBEC Gene Deletion Polymorphism , 2007, PLoS genetics.
[116] Robert M Grant,et al. Target Cell APOBEC3C Can Induce Limited G-to-A Mutation in HIV-1 , 2007, PLoS pathogens.
[117] M. Shimura,et al. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition , 2007, Nucleic acids research.
[118] Kuan-Teh Jeang,et al. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation , 2007, Nature Reviews Cancer.
[119] Y. Xiong,et al. Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[120] Darius Moradpour,et al. Replication of hepatitis C virus , 2007, Nature Reviews Microbiology.
[121] Keyang Chen,et al. Virion-associated Uracil DNA Glycosylase-2 and Apurinic/Apyrimidinic Endonuclease Are Involved in the Degradation of APOBEC3G-edited Nascent HIV-1 DNA* , 2007, Journal of Biological Chemistry.
[122] A. Gronenborn,et al. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G , 2007, Nucleic acids research.
[123] S. Pillai,et al. Turning up the volume on mutational pressure: Is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3) , 2008, Retrovirology.
[124] J. Kappes,et al. Cytidine Deaminases APOBEC3G and APOBEC3F Interact with Human Immunodeficiency Virus Type 1 Integrase and Inhibit Proviral DNA Formation , 2007, Journal of Virology.
[125] G. Schumann. APOBEC3 proteins: major players in intracellular defence against LINE-1-mediated retrotransposition. , 2007, Biochemical Society transactions.
[126] P. Spearman,et al. APOBEC3G Multimers Are Recruited to the Plasma Membrane for Packaging into Human Immunodeficiency Virus Type 1 Virus-Like Particles in an RNA-Dependent Process Requiring the NC Basic Linker , 2007, Journal of Virology.
[127] M. Malim,et al. APOBEC3F Can Inhibit the Accumulation of HIV-1 Reverse Transcription Products in the Absence of Hypermutation , 2007, Journal of Biological Chemistry.
[128] K. Shindo,et al. Evolution of HIV-1 Isolates that Use a Novel Vif-Independent Mechanism to Resist Restriction by Human APOBEC3G , 2008, Current Biology.
[129] S. Wain-Hobson,et al. Evidence for Editing of Human Papillomavirus DNA by APOBEC3 in Benign and Precancerous Lesions , 2008, Science.
[130] S. O’Brien,et al. Functions, structure, and read-through alternative splicing of feline APOBEC3 genes , 2008, Genome Biology.
[131] N. Navaratnam,et al. APOBEC and iNOS are not the main intracellular effectors of IFN-gamma-mediated inactivation of Hepatitis B virus replication. , 2008, Antiviral research.
[132] Timothy P. L. Smith,et al. The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals , 2008, BMC Molecular Biology.
[133] John J. Welch,et al. Conserved Footprints of APOBEC3G on Hypermutated Human Immunodeficiency Virus Type 1 and Human Endogenous Retrovirus HERV-K(HML2) Sequences , 2008, Journal of Virology.
[134] Ariana Harari,et al. Polymorphisms and Splice Variants Influence the Antiretroviral Activity of Human APOBEC3H , 2008, Journal of Virology.
[135] M. Malim,et al. Comparison of Cellular Ribonucleoprotein Complexes Associated with the APOBEC3F and APOBEC3G Antiviral Proteins , 2008, Journal of Virology.
[136] M. Neuberger,et al. Human APOBEC3G Can Restrict Retroviral Infection in Avian Cells and Acts Independently of both UNG and SMUG1 , 2008, Journal of Virology.
[137] H. Blum,et al. Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H. , 2008, The Journal of general virology.
[138] Wei Zhang,et al. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression , 2007, Cellular microbiology.
[139] M. Malim,et al. APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts , 2008, PLoS pathogens.
[140] A. Gewirtzman,et al. Mucocutaneous Manifestations of Epstein-Barr Virus Infection , 2008, American journal of clinical dermatology.
[141] J. Wedekind,et al. Nuclear Exclusion of the HIV-1 Host Defense Factor APOBEC3G Requires a Novel Cytoplasmic Retention Signal and Is Not Dependent on RNA Binding* , 2008, Journal of Biological Chemistry.
[142] Hong Cao,et al. Small-molecule inhibition of HIV-1 Vif , 2008, Nature Biotechnology.
[143] S. Matsushita,et al. The antiretroviral potency of APOBEC1 deaminase from small animal species , 2008, Nucleic acids research.
[144] Xiaojun Wang,et al. Human Cytidine Deaminase APOBEC3H Restricts HIV-1 Replication* , 2008, Journal of Biological Chemistry.
[145] G. Reyes-Terán,et al. APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression , 2009, Retrovirology.
[146] S. Mboup,et al. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals. , 2008, AIDS research and human retroviruses.
[147] C. Tian,et al. Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C. , 2008, Virology.
[148] M. Emerman,et al. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. , 2008, Cell host & microbe.
[149] Ma Luo,et al. Human Immunodeficiency Virus (HIV) Type 1 Proviral Hypermutation Correlates with CD4 Count in HIV-Infected Women from Kenya , 2008, Journal of Virology.
[150] J. Sankalé,et al. Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F. , 2008, The Journal of infectious diseases.
[151] A. Rathore,et al. Absence of H186R polymorphism in exon 4 of the APOBEC3G gene among North Indian individuals. , 2008, Genetic testing.
[152] W. Greene,et al. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. , 2008, Annual review of immunology.
[153] T. Hope,et al. APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells. , 2008, Virology.
[154] Ariana Harari,et al. Cytidine deamination induced HIV-1 drug resistance , 2008, Proceedings of the National Academy of Sciences.
[155] Bette Korber,et al. HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC , 2009, PLoS pathogens.
[156] D. Trono,et al. APOBEC3G-Depleted Resting CD4+ T Cells Remain Refractory to HIV1 Infection , 2009, PloS one.
[157] C. Tian,et al. Sole copy of Z2‐type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV‐1. , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[158] Osamu Takeuchi,et al. Innate immunity to virus infection , 2009, Immunological reviews.
[159] Yusuke Nakamura,et al. Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.
[160] R. Harris,et al. AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity , 2009, Nucleic acids research.
[161] J. Hultquist,et al. Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS. , 2009, Future virology.
[162] S. Wain-Hobson,et al. Genetic Editing of HBV DNA by Monodomain Human APOBEC3 Cytidine Deaminases and the Recombinant Nature of APOBEC3G , 2009, PloS one.
[163] M. Khan,et al. Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization , 2009, Retrovirology.
[164] J. Goedert,et al. APOBEC3B deletion and risk of HIV-1 acquisition. , 2009, The Journal of infectious diseases.
[165] M. Neuberger,et al. Deficiency in APOBEC2 Leads to a Shift in Muscle Fiber Type, Diminished Body Mass, and Myopathy , 2009, The Journal of Biological Chemistry.
[166] V. Pathak,et al. Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance , 2009, PLoS pathogens.
[167] Aijaz Ahmed,et al. Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. , 2009, The Journal of infectious diseases.
[168] M. Sitbon,et al. Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. , 2009, Journal of molecular biology.
[169] R. McClelland,et al. Analysis of the Percentage of Human Immunodeficiency Virus Type 1 Sequences That Are Hypermutated and Markers of Disease Progression in a Longitudinal Cohort, Including One Individual with a Partially Defective Vif , 2009, Journal of Virology.
[170] J. Levy. HIV pathogenesis: 25 years of progress and persistent challenges , 2009, AIDS.
[171] M. Kamata,et al. Reassessing the Role of APOBEC3G in Human Immunodeficiency Virus Type 1 Infection of Quiescent CD4+ T-Cells , 2009, PLoS pathogens.
[172] S. Wain-Hobson,et al. Human APOBEC1 cytidine deaminase edits HBV DNA , 2009, Retrovirology.
[173] Y. Kamatani,et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians , 2009, Nature Genetics.
[174] Y. Kawaguchi,et al. APOBEC1-Mediated Editing and Attenuation of Herpes Simplex Virus 1 DNA Indicate That Neurons Have an Antiviral Role during Herpes Simplex Encephalitis , 2010, Journal of Virology.
[175] John S. Albin,et al. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics , 2010, Expert Reviews in Molecular Medicine.
[176] T. Ndung’u,et al. APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load , 2010, AIDS.
[177] S. Bernacchi,et al. HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation , 2009, Nucleic acids research.
[178] C. Winkler,et al. Host genes associated with HIV/AIDS: advances in gene discovery. , 2010, Trends in genetics : TIG.
[179] O. Schwartz,et al. The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells , 2010, The Journal of experimental medicine.
[180] V. Mazzaferro,et al. Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis , 2010, PLoS pathogens.
[181] Quan Zhang,et al. The cellular source for APOBEC3G's incorporation into HIV-1 , 2011, Retrovirology.
[182] P. Green,et al. Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis , 2010, Viruses.
[183] M. Malim,et al. Human APOBEC3G-Mediated Editing Can Promote HIV-1 Sequence Diversification and Accelerate Adaptation to Selective Pressure , 2010, Journal of Virology.
[184] The Associations of hA3G and hA3B mRNA Levels With HIV Disease Progression Among HIV-Infected Individuals of China , 2010, Journal of acquired immune deficiency syndromes.
[185] Ariana Harari,et al. Moderate Influence of Human APOBEC3F on HIV-1 Replication in Primary Lymphocytes , 2010, Journal of Virology.
[186] M. Matsuoka,et al. APOBEC3G Generates Nonsense Mutations in Human T-Cell Leukemia Virus Type 1 Proviral Genomes In Vivo , 2010, Journal of Virology.
[187] Jian-Dong Jiang,et al. Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3G* , 2010, The Journal of Biological Chemistry.
[188] W. Brown,et al. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction , 2010, Nucleic acids research.
[189] M. Pellegrini,et al. Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency , 2010, Nature.
[190] T. Nakajima,et al. No evidence of an association between the APOBEC3B deletion polymorphism and susceptibility to HIV infection and AIDS in Japanese and Indian populations. , 2010, The Journal of infectious diseases.
[191] M. Stenglein,et al. APOBEC3 proteins mediate the clearance of foreign DNA from human cells , 2010, Nature Structural &Molecular Biology.
[192] V. Pathak,et al. APOBEC3F and APOBEC3G Inhibit HIV-1 DNA Integration by Different Mechanisms , 2010, Journal of Virology.
[193] L. M. Mansky,et al. APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis , 2010, Journal of Virology.
[194] Fuchu He,et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers , 2010, Nature Genetics.
[195] Helen M. Blau,et al. Reprogramming towards pluripotency requires AID-dependent DNA demethylation , 2010, Nature.
[196] A. Mangano,et al. Effect of HIV-1 Vif variability on progression to pediatric AIDS and its association with APOBEC3G and CUL5 polymorphisms. , 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[197] M. Emerman,et al. Polymorphism in Human APOBEC3H Affects a Phenotype Dominant for Subcellular Localization and Antiviral Activity , 2011, Journal of Virology.
[198] C. Wachihi,et al. The role of G protein gene GNB3 C825T Polymorphism in HIV-1 acquisition, progression and immune activation , 2012, Retrovirology.
[199] V. I. Mayorov,et al. Mutator effects and mutation signatures of editing deaminases produced in bacteria and yeast , 2011, Biochemistry (Moscow).
[200] C. Chisholm,et al. Cutaneous infections caused by Herpesviridae: a review. , 2011, Archives of pathology & laboratory medicine.
[201] T. Mizukami,et al. An anti-HIV-1 compound that increases steady-state expression of apoplipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G. , 2011, International journal of molecular medicine.
[202] N. Bresolin,et al. A POSITIVELY SELECTED APOBEC3H HAPLOTYPE IS ASSOCIATED WITH NATURAL RESISTANCE TO HIV‐1 INFECTION , 2011, Evolution; international journal of organic evolution.
[203] A. Meyerhans,et al. Genetic Editing of Herpes Simplex Virus 1 and Epstein-Barr Herpesvirus Genomes by Human APOBEC3 Cytidine Deaminases in Culture and In Vivo , 2011, Journal of Virology.
[204] M. Soares,et al. Expression of APOBEC3G/3F and G-to-A Hypermutation Levels in HIV-1-Infected Children with Different Profiles of Disease Progression , 2011, PloS one.
[205] Xiaojun Wang,et al. Analysis of Human APOBEC3H Haplotypes and Anti-Human Immunodeficiency Virus Type 1 Activity , 2011, Journal of Virology.
[206] E. Kurt-Jones,et al. Pattern Recognition Receptors and the Innate Immune Response to Viral Infection , 2011, Viruses.
[207] Rocío Aller,et al. Perfiles de expresión génica en las primeras doce semanas de tratamiento en pacientes con hepatitis C crónica , 2011 .
[208] F. Hecht,et al. APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection. , 2011, Human immunology.
[209] [Gene expression profiling in the first twelve weeks of treatment in chronic hepatitis C patients]. , 2011, Enfermedades infecciosas y microbiologia clinica.
[210] K. Shianna,et al. Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure , 2011, PloS one.
[211] Jian-Dong Jiang,et al. Host apolipoprotein b messenger RNA‐editing enzyme catalytic polypeptide‐like 3G is an innate defensive factor and drug target against hepatitis C virus , 2011, Hepatology.
[212] M. D. Di Bari,et al. Assessment of the Genetic Susceptibility of Sheep to Scrapie by Protein Misfolding Cyclic Amplification and Comparison with Experimental Scrapie Transmission Studies , 2011, Journal of Virology.
[213] K. Collins,et al. The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells , 2011, Nature Immunology.
[214] P. Pineau,et al. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism , 2011, Proceedings of the National Academy of Sciences.
[215] A. Chicca,et al. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function. , 2011, Molecular biology and evolution.
[216] T. Heidmann,et al. Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons , 2011, Nucleic acids research.
[217] R. Diaz,et al. Loci polymorphisms of the APOBEC3G gene in HIV type 1-infected Brazilians. , 2011, AIDS research and human retroviruses.
[218] G. Ming,et al. Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain , 2011, Cell.
[219] Michael M. Mwangi,et al. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA editing targets in transcript 3′ UTRs , 2010, Nature Structural &Molecular Biology.
[220] Lela Lackey,et al. APOBEC3B and AID have similar nuclear import mechanisms. , 2012, Journal of molecular biology.
[221] S. Conticello. Creative deaminases, self‐inflicted damage, and genome evolution , 2012, Annals of the New York Academy of Sciences.
[222] Hongbing Shen,et al. GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers , 2012, PLoS genetics.
[223] A. Iwasaki. A virological view of innate immune recognition. , 2012, Annual review of microbiology.
[224] M. Malim,et al. HIV-1 Replication and APOBEC3 Antiviral Activity Are Not Regulated by P Bodies , 2012, Journal of Virology.
[225] M. Malim,et al. Suppression of HIV-1 Infection by APOBEC3 Proteins in Primary Human CD4+ T Cells Is Associated with Inhibition of Processive Reverse Transcription as Well as Excessive Cytidine Deamination , 2012, Journal of Virology.
[226] M. Wabl,et al. LINE-1 Retroelements Complexed and Inhibited by Activation Induced Cytidine Deaminase , 2012, PloS one.
[227] G. Kobinger,et al. The Cellular Antiviral Protein APOBEC3G Interacts with HIV-1 Reverse Transcriptase and Inhibits Its Function during Viral Replication , 2012, Journal of Virology.
[228] V. Pathak,et al. APOBEC3G Restricts HIV-1 to a Greater Extent than APOBEC3F and APOBEC3DE in Human Primary CD4+ T Cells and Macrophages , 2012, Journal of Virology.
[229] A. Mangano,et al. APOBEC3-mediated editing in HIV type 1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability. , 2012, AIDS research and human retroviruses.
[230] V. Simon,et al. APOBEC3A, APOBEC3B, and APOBEC3H Haplotype 2 Restrict Human T-Lymphotropic Virus Type 1 , 2012, Journal of Virology.
[231] V. Calvez,et al. E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure , 2012, AIDS.
[232] Andrew D. Johnson,et al. A Genome-Wide Association Meta-Analysis of Circulating Sex Hormone–Binding Globulin Reveals Multiple Loci Implicated in Sex Steroid Hormone Regulation , 2012, PLoS genetics.
[233] N. Krogan,et al. First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G. , 2012, ACS chemical biology.
[234] HaroldC. Smith,et al. Functions and regulation of the APOBEC family of proteins. , 2012, Seminars in cell & developmental biology.
[235] R. D’Aquila,et al. APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo. , 2012, Virology.
[236] C. Münk,et al. An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammals , 2012, BMC Evolutionary Biology.
[237] Hanneke Schuitemaker,et al. Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics , 2012, Retrovirology.
[238] D. Häussinger,et al. Running Loose or Getting Lost: How HIV-1 Counters and Capitalizes on APOBEC3-Induced Mutagenesis through Its Vif Protein , 2012, Viruses.
[239] J. Fellay,et al. Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo , 2012, Proceedings of the National Academy of Sciences.
[240] Paul D. Cotter,et al. Nucleic acid-based approaches to investigate microbial-related cheese quality defects , 2012, Front. Microbio..
[241] Ming Li,et al. Small‐Molecule APOBEC3G DNA Cytosine Deaminase Inhibitors Based on a 4‐Amino‐1,2,4‐triazole‐3‐thiol Scaffold , 2013, ChemMedChem.
[242] P. Pineau,et al. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population , 2013, Journal of viral hepatitis.
[243] S. Spector,et al. Genetic Variants in the Host Restriction Factor APOBEC3G are Associated With HIV-1–Related Disease Progression and Central Nervous System Impairment in Children , 2013, Journal of acquired immune deficiency syndromes.
[244] Terumasa Ikeda,et al. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases , 2013, Front. Microbio..
[245] N. A. Temiz,et al. APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.
[246] Lela Lackey,et al. Endogenous APOBEC3A DNA Cytosine Deaminase Is Cytoplasmic and Nongenotoxic* , 2013, The Journal of Biological Chemistry.
[247] W. Tan,et al. Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma. , 2013, Human molecular genetics.